- • Up to 20%-50%* off first purchase
- • Bulk quantities available
- • Citation Reward application
AAV ProDUCTS & SERVICE
AAV TECHNICAL RESOURCE
Supports
- Talk to our Expert:
[email protected] -
Talk to our sales:
[email protected]
Protocol Library Download
 |
 |
AAV-Rh.10 Rep-Cap plasmid (serotype Rh.10-specific AAV RC-Rh.10 plasmids) (Amp and Kanamycin) (GeneMedi Owned)
GeneMedi's AAV-Rh.10 Rep-Cap plasmid supplies the AAV2 Rep (replication) proteins and the AAV-Rh.10 capsid protein.
You can produce AAV-Rh.10 particle in 293T cell line in high titer using GeneMedi's AAV-Rh.10 Rep-Cap plasmid with GM's AAV expression vector (overexpression or shRNA) and AAV helper plasmid.
The tissue tropism of AAV-Rh.10 vector has been validated in neuron(CNS), lung, liver, heart and muscle, with potential applications in tissue-specific gene therapy.
GeneMedi offers both Ampicillin (Amp) resistance and Kanamycin (Kan) resistance for the AAV Rep-Cap Plasmids.
Go to AAV
vector system
>>
Manual
Product Description
| Cat.NO | Product Name | Organization Type | Price(In USD) | ||
|---|---|---|---|---|---|
| P-RC14 | AAV-Rh.10 Rep-Cap Plasmid (Amp resistance) Size：5ug | Academic | 1115 | ||
| P-RC14 | AAV-Rh.10 Rep-Cap Plasmid (Amp resistance) Size：5ug | Industry R&D (excluding CRO&CDMO&CXO) |
|||
| P-RC14 | AAV-Rh.10 Rep-Cap Plasmid (Amp resistance) Size：5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-RC14 | AAV-Rh.10 Rep-Cap Plasmid (Amp resistance) Size：≥10mg |
All | |||
| P-RC14-Kan | AAV-Rh.10 Rep-Cap Plasmid (Kan resistance) Size：≥10mg |
All | |||
| P-PK14 | AAV-Rh.10 Vector
System (Amp resistance)
1. AAV-Rh.10 Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug |
Academic | 2388 | ||
| P-PK14 | AAV-Rh.10 Vector
System (Amp resistance)
1. AAV-Rh.10 Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | Industry R&D (excluding CRO&CDMO&CXO) |
|||
| P-PK14 | AAV-Rh.10 Vector
System (Amp resistance)
1. AAV-Rh.10 Rep-Cap Plasmid, 5ug 2. AAV Helper Plasmid, 5ug 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01), 5ug | CRO&CDMO& CXO&CMC& Manufacturing company |
|||
| P-PK14 | AAV-Rh.10 Vector
System (Amp resistance)
1. AAV-Rh.10 Rep-Cap Plasmid, ≥10mg 2. AAV Helper Plasmid, ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (P-AAVV-B01-Kan), ≥10mg |
All | |||
| P-PK14-Kan | AAV-Rh.10 Vector
System(Kan resistance)
1. AAV-Rh.10 Rep-Cap Plasmid(Kan resistance), ≥10mg 2. AAV Helper Plasmid(Kan resistance), ≥10mg 3. pGMAAV-CMV-MCS-T2A-ZsGreen (Kan resistance) (P-AAVV-B01-Kan), ≥10mg |
All | |||
|
GeneMedi offers both seed and amplification services for the Amp-resistant AAV Rep-Cap Plasmid. GeneMedi only offers amplification services and do not provide seed for the Kan-resistant AAV Rep-Cap Plasmid currently. |
|||||
| If you want to obtain higher quantities of plasmids (mg), please visit GM TransExcellent Plasmid DNA Rapid Preparation Service. | |||||
|
Terms of sale: For Seed (5ug): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for any other party. For plasmid production& amplification (≥10mg): The purchaser may not reverse engineer this product to extract the sequence for independent use. The purchaser may not transfer this product to others for manufacturing purposes. The purchaser may not use this material to manufacture this product for themselves or any other party. |
|||||
Citation
| Title | Publication | Date |
|---|---|---|
| IFNα Potentiates Anti-PD-1 Efficacy by Remodeling Glucose Metabolism in the Hepatocellular Carcinoma Microenvironment | Cancer Discovery | 2022/4/12 |
| Hypoxia-induced circWSB1 promotes breast cancer progression through destabilizing p53 by interacting with USP10 | Molecular Cancer | 2022/3/10 |
| Downregulation of MUS81 expression inhibits cell migration and maintains EBV latent infection through miR‐BART9‐5p in EBV‐associated gastric cancer | Journal of Medical Virology | 2023/4/13 |
| Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy | Nature Communications | 2023/5/3 |
| PSD?93 up?regulates the synaptic activity of corticotropin?releasing hormone neurons in the paraventricular nucleus in depression | Acta Neuropathologica | 2021/9/18 |
| NDFIP1 limits cellular TAZ accumulation via exosomal sorting to inhibit NSCLC proliferation | Protein & Cell | 2022/9/21 |
| The essential role of PRAK in tumor metastasis and its therapeutic potential | nature communication | 2021/3/19 |
| Two Hippo signaling modules orchestrate liver size and tumorigenesis | The EMBO Journal | 2023/3/15 |
| [PDF] Development of a rare earth nanoprobe enables in vivo real-time detection of sentinel lymph node metastasis of breast cancer using NIR-IIb imaging | Cancer Research | 2023/8/4 |
| Bioactive glass nanoparticles inhibit osteoclast differentiation and osteoporotic bone loss by activating lncRNA NRON expression in the extracellular vesicles derived from bone marrow mesenchymal stem cells | Biomaterials | 2022/2/24 |
Validation data
No data found
Associated products and services
| Products & Service | Products & Service Information |
|---|---|
| AAV Packaging service | Detail |
| Promise-ORF™ viral CDNA library | Detail |
| Plasmid DNA Rapid Preparation Service | Detail |
Facebook
LinkedIn
Twitter
